Inventor · disambiguated record
Michel Perricaudet
Also filed as: PERRICAUDET MICHEL
38 granted patents·22 pending applications·1,116 citations·filing 1992–2013
98Inventor score
Files withAVENTIS PHARMA SA20RHONE POULENC RORER SA11CENTRE NAT RECH SCIENT4GENCELL SA2PASTEUR INSTITUT2
Top patents by PatentIndex Score
60 records- 0195US7033826B2Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenovirusesAVENTIS PHARMA SA·Filed 2002·Granted Apr 25, 2006·62 cites·10 claims
- 0293US6127175ACells for the production of recombinant adenovirusesRHONE POULENC RORER SA·Filed 1996·Granted Oct 3, 2000·182 cites·33 claims
- 0392US6013638AAdenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lungUS HEALTH·Filed 1993·Granted Jan 11, 2000·108 cites·14 claims
- 0490US6911199B2Targeted adenovirus vectors for delivery of heterologous genesAVENTIS PHARMA SA·Filed 2001·Granted Jun 28, 2005·38 cites·46 claims
- 0589US5789390AMethod for preparing recombinant adeno-associated viruses (AAV), and uses thereofRHONE POULENC RORER SA·Filed 1995·Granted Aug 4, 1998·118 cites·26 claims
- 0688US6756523B1Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brainAVENTIS PHARMA SA·Filed 1995·Granted Jun 29, 2004·96 cites·108 claims
- 0785US6669942B2Defective adenoviruses including a therapeutic gene and an immunoprotectove geneAVENTIS PHARMA SA·Filed 1995·Granted Dec 30, 2003·50 cites·28 claims
- 0883US7306793B2Defective recombinant adenoviruses expressing cytokines for antitumor treatmentCENTRE NAT RECH SCIENT·Filed 2004·Granted Dec 11, 2007·11 cites·9 claims
- 0982US6136594AReplication deficient recombinant adenovirus vectorTRANSGENE SA·Filed 1995·Granted Oct 24, 2000·34 cites·15 claims
- 1082US5866551ARecombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemiasRHONE POULENC RORER SA·Filed 1994·Granted Feb 2, 1999·40 cites·11 claims
- 1178US6387670B1Method for producing recombinant virusAVENTIS PHARMA SA·Filed 1997·Granted May 14, 2002·38 cites·27 claims
- 1276US6033885AIntegrative recombinant adenoviruses, preparation thereof and therapeutical uses thereofRHONE POULENC RORER SA·Filed 1995·Granted Mar 7, 2000·38 cites·31 claims
- 1374US6814962B1Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to sameAVENTIS PHARMA SA·Filed 2000·Granted Nov 9, 2004·3 cites·15 claims
- 1473US6210963B1Recombinant cells from the monocyte-macrophage cell line for gene therapyINST NAT SANTE RECH MED·Filed 1994·Granted Apr 3, 2001·44 cites·15 claims
- 1572US6464998B1Composition for the in vivo production of therapeutic productsAVENTIS PHARMA SA·Filed 1994·Granted Oct 15, 2002·28 cites·25 claims
- 1669US6294377B1Adenoviral vectors of canine originRHONE POULENC RORER SA·Filed 1994·Granted Sep 25, 2001·23 cites·6 claims
- 1764US6245330B1Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF)AVENTIS PHARMA SA·Filed 1995·Granted Jun 12, 2001·28 cites·24 claims
- 1863US9862931B2Adenovirus vaccine vectorsBENIHOUD KARIM·Filed 2011·Granted Jan 9, 2018·2 cites·10 claims
- 1961US6482617B2Viable contaminant particle free adenoviruses, their preparation and useAVENTIS PHARMA SA·Filed 2001·Granted Nov 19, 2002·2 cites·22 claims
- 2061US2009257981A1Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to sameUNIV BRITISH COLUMBIA·Filed 2007·Application pending·0 cites
- 2159US6410011B1Gene therapy for restenosis using an adenoviral vectorAVENTIS PHARMA SA·Filed 1995·Granted Jun 25, 2002·15 cites·24 claims
- 2258US6489142B1Methods and compositions for producing viral particlesAVENTIS PHARMA SA·Filed 1999·Granted Dec 3, 2002·12 cites·26 claims
- 2357US6811774B2Defective recombinant adenoviruses expressing cytokines for antitumor treatmentCENTRE NAT RECH SCIENT·Filed 1998·Granted Nov 2, 2004·17 cites·1 claims
- 2457US6420170B1Recombinant adenoviruses containing an inducible promoter controlling a gene of viral originAVENTIS PHARMA SA·Filed 1996·Granted Jul 16, 2002·10 cites·32 claims
- 2557US2003086907A1Recombinant adenoviruses and use thereof in gene therapy for treating eye diseasesAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 2656US5837531ARecombinant adenoviruses for gene therapy in cancersRHONE POULENC RORER SA·Filed 1994·Granted Nov 17, 1998·14 cites·16 claims
- 2755US6685934B1Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)AVENTIS PHARMA SA·Filed 1995·Granted Feb 3, 2004·12 cites·21 claims
- 2855US2005069523A1Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)RHONE POULENC RORER SA·Filed 2003·Application pending·0 cites
- 2954US6638502B1Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumorsGENCELL SAS·Filed 1998·Granted Oct 28, 2003·20 cites·14 claims
- 3053US6426216B1Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoterPASTEUR INSTITUT·Filed 1995·Granted Jul 30, 2002·9 cites·16 claims
- 3153US2002164304A1Adenovirus-mediated transfer of genes to the lungTRANSGENE·Filed 2001·Application pending·0 cites
- 3253US2013164262A1Recombinant Viruses and their Use for Treatment of Atherosclerosis and Othe Forms of Coronary Artery Disease and Method, Reagent, and Kit for Evaluating Susceptibiity to SameBENOIT PATRICK·Filed 2012·Application pending·0 cites
- 3353US2004265273A1Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumorsFiled 2003·Application pending·0 cites
- 3453US2003022356A1Method for producing recombinant virusFiled 2002·Application pending·0 cites
- 3552US6630322B1Generating replicating molecules in vivoGENCELL SA·Filed 1997·Granted Oct 7, 2003·10 cites·20 claims
- 3652US6200798B1Defective recombinant adenoviruses with inactivated IVa2 geneRHONE POULENC RORER SA·Filed 1995·Granted Mar 13, 2001·8 cites·26 claims
- 3752US2002068052A1Recombinant adenoviruses and use thereof in gene therapy for treating eye diseasesAVENTIS PHARMA SA·Filed 2001·Application pending·0 cites
- 3851USRE38556ERecombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemiasAVENTIS PHARMA SA·Filed 1994·Granted Jul 13, 2004·7 cites·17 claims
- 3951US2005244381A1Adenovirus including a gene coding for a superoxide dismutaseAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 4049US2006002893A1Targeted adenovirus vectors for delivery of heterologous genesVIGNE EMMANUELLE·Filed 2005·Application pending·0 cites
- 4148US2004224409A1Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)Filed 2003·Application pending·0 cites
- 4248US2002094324A1Gene therapy for restenosis using an adenoviral vectorAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 4346US6312946B1Viable contaminant particle free adenoviruses, their prepartion and useRHONE POULENC RORER SA·Filed 1995·Granted Nov 6, 2001·20 cites·23 claims
- 4445US2004265276A1Medicinal combination useful for in vivo exogenic transfection and expressionFiled 2004·Application pending·0 cites
- 4543US2013210898A1Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to sameAVENTIS PHARMA SA·Filed 2013·Application pending·0 cites
- 4643US2003096787A1Defective adenovirus vectors and use thereof in gene therapyFiled 2002·Application pending·0 cites
- 4740US6743623B2Viral recombinant vectors for expression in muscle cellsCENTRE NAT RECH SCIENT·Filed 1999·Granted Jun 1, 2004·4 cites·4 claims
- 4840US6696420B1Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous proteinPASTEUR INSTITUT·Filed 1993·Granted Feb 24, 2004·5 cites·24 claims
- 4939US8642028B2Recombinant adenoviruses encoding the specific iodine transporter (NIS)PERRICAUDET MICHEL·Filed 2012·Granted Feb 4, 2014·0 cites·7 claims
- 5038US2009280089A1Inhibition of the liver tropism of adenoviral vectorsROUSSY INST GUSTAVE·Filed 2006·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michel Perricaudet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →